´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of SABCS in KOREA (San Antonio Breast Cancer Symposium) : 2023-02-04±³À°ÀÏÀÚ : 2023-02-04
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦
±³À°ÁÖÁ¦ :
Best of SABCS in KOREA (San Antonio Breast Cancer Symposium)ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857
À̸ÞÀÏ :
meetings@ksmo.or.kr ±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í ±³¼ö/Àü¹®ÀÇ/¹Ú»ç±Þ ¿¬±¸¿ø (»çÀü)50,000 (ÇöÀå)60,000 ÀüÀÓÀÇ/Àü°øÀÇ/¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø ¹× Çлý/°£È£»ç/ °øº¸ÀÇ/±ºÀÇ°ü/¾à»ç (»çÀü)30,000 (ÇöÀå)40,000 ¾÷ü ¹× ±âŸ (»çÀü)70,000 (ÇöÀå)80,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-04 09:00~09:25 Updates of basic science and insights into tumor biology ¹ÚÀÎÇý(°í·Á´ë±¸·Îº´¿ø)
±³À°½Ã°£ 02-04 09:25~09:50 Spatial Single cell approaches for translational research and biomarker discovery ±èÁöÇü(°³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 02-04 09:50~10:15 Tumor immunology and novel strategies for immunotherapy ±èÁö¿¬(»ï¼º¼¿ïº´¿ø)
Åä·Ð 02-04 10:15~10:30 Q & A ()
±³À°½Ã°£ 02-04 10:45~11:10 Updates in surgical management and management of breast cancer risk ±èÁö¼±(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 02-04 11:10~11:35 Updates in Radiotherapy ¼ÛÁøÈ£(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 02-04 11:35~11:50 Defining HER2-low disease : Pathologist À¯ÇѼ®(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 02-04 11:50~12:05 Defining HER2-low disease : Medical oncologist ¼°æÁø(ºÐ´ç¼¿ï´ëº´¿ø)
Åä·Ð 02-04 12:05~12:20 Q & A ()
±³À°½Ã°£ 02-04 12:20~13:00 The new leap forward in the treatment of metastatic breast cancer ¹Ú°æÈ(°í·Á´ë ±¸·Îº´¿ø)
±³À°½Ã°£ 02-04 13:30~14:00 Advances in HR+/HER2- Early breast cancer ÀÌ´ë¿ø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 02-04 14:00~14:30 Advances in HR+/HER2- Metastatic breast cancer ÀÌÁöÀº(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 02-04 14:30~14:55 New insights in endocrine resistance and novel endocrine treatment äÈñÁ¤(±¹¸³¾Ï¼¾ÅÍ)
Åä·Ð 02-04 14:55~15:15 Q & A ()
±³À°½Ã°£ 02-04 15:30~15:55 HER2-positive breast cancer ÀÌ°æÀº(ÀÌ´ë¸ñµ¿º´¿ø)
±³À°½Ã°£ 02-04 15:55~16:20 TNBC and novel therapeutic approaches ¾ÈÈñ°æ(°¡Ãµ´ë±æº´¿ø)
Åä·Ð 02-04 16:20~16:30 Q & A ()